Chinese Traditional and Herbal Drugs
|
2025, 56(2): 731-741
Application progress on new omics technology in toxicity evaluation of traditional Chinese medicine
Full
LI Ding1, WANG Wanying2, SUN Lu3, LEI Yan4, KONG Jiao5, HE Tao6, MA Kaiyue7, LIU Chuanxin2
Affiliations
1 Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University &
2 enan Cancer Hospital, Zhengzhou 450008, China;
3 Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, the First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China;
4 College of Chinese Materia Medica and Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China;
5 Department of General Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China;
6 Laboratory of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China;
7 Institute of Pharmacoinformatics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
doi: 10.7501/j.issn.0253-2670.2025.02.033
Outline
The integration of multi-omics strategies has opened up a new research perspective for the safety evaluation of traditional Chinese medicine. Cutting-edge omics technologies such as single-cell transcriptomics, protein modification omics, metabolomics and imaging omics have realized the mechanism of toxic effects of traditional Chinese medicine (TCM) from different levels of molecules, cells, tissues, systems and even the whole, helping to identify potential toxic components of TCM and discover characteristic biomarkers. Based on CNKI, PubMed, Web of Science and other authoritative databases, literature related to multi-omics technology and TCM safety evaluation/toxicity studies in the past 10 years was searched and summarized. This paper reviewed the status of toxicity research of TCM, systematically expounded and summarized the application progress of various new omics technologies in toxicity research of TCM, and provided reference for promoting the combined application of multi-omics as a new strategy for toxicity research of traditional Chinese medicine. In the future, the progress of high-throughput data processing technology is expected to promote multi-omics technology to make greater contributions to the improvement of traditional Chinese medicine safety evaluation system.
omics technology
/
multi-omics strategy
/
traditional Chinese medicine
/
toxicity
/
safety evaluation
/
single-cell transcriptomics
/
protein modification omics
/
metabolomics
/
imaging omics
李丁, 王婉瑩, 孙璐, 雷艳, 孔娇, 何涛, 马恺悦, 刘传鑫.
组学新技术在中药毒性研究中的应用进展.
中草药,
2025
, 56
(2)
: 731
-741
.
DOI: 10.7501/j.issn.0253-2670.2025.02.033
LI Ding, WANG Wanying, SUN Lu, LEI Yan, KONG Jiao, HE Tao, MA Kaiyue, LIU Chuanxin.
Application progress on new omics technology in toxicity evaluation of traditional Chinese medicine[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(2)
: 731
-741
.
DOI: 10.7501/j.issn.0253-2670.2025.02.033
Year 2025 volume 56 Issue 2
53
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.02.033
- Receive Date:2024-09-12
- Online Date:2026-11-13